ADAP - Adaptimmune Therapeutics plc Stock Trading

Adaptimmune Therapeutics plc(NASDAQ: ADAP) stock trading, description, contact, officers and directors.

About Adaptimmune Therapeutics plc

Not available

Stock Information

Adaptimmune Therapeutics plc Company Name:

ADAP Stock Symbol:

NASDAQ Market:

Get ADAP Alerts

News, Short Squeeze, Breakout and More Instantly...

ADAP - Adaptimmune to Report Q3 2021 Financial Results and Business Update on Thursday, November 4, 2021

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and provide a business update for the third quarter ended September 30, 2021, before the US mar...
ADAP - Adaptimmune to Present Data Updates at Upcoming CTOS and SITC Meetings

- Clinical update and translational data from SPEARHEAD-1 in patients with synovial sarcoma and MRCLS to be presented at CTOS - - The Company will host its first virtual medical symposium at CTOS - - Translational data from Phase 1 SURPASS trial to be presented at SITC - P...
ADAP - Why Adaptimmune Therapeutics Was Sinking This Week

In an about-face from its impressive performance last week, Adaptimmune Therapeutics (NASDAQ: ADAP) stock declined by nearly 14% over the past five trading days. This occurred even though the cancer-focused biotech actually divulged some good news. That news was certainly encour...